Brunei Darussalam vs China: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Brunei Darussalam
0.0%
in 2025
China
0.0%
in 2025
Brunei Darussalam rank
165th
China rank
165th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Brunei Darussalam
- China
How they compare
Brunei Darussalam currently reports 0.0% against 0.0% in China, a difference of 0.0%.
Across all 18 years both countries report, China has been ahead every year.
Brunei Darussalam ranks 165th and China ranks 165th of 192 countries.
Head to head by decade
| Decade | Brunei Darussalam | China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Brunei Darussalam or China?
- Brunei Darussalam, at 0.0% against 0.0% in China as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Brunei Darussalam and China?
- 0.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and China?
- 18 years are reported by both, from 2008 to 2025.
- How do Brunei Darussalam and China rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Brunei Darussalam ranks 165th and China ranks 165th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.